High Efficacy of Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir in Hepatitis C Genotypes 4 and 1 –infected Patients with Severe Chronic Kidney Disease

ConclusionA 12‐week regimen of OBV/PTV/r ± DSV with or without RBV is highly effective with a favourable safety profile amongst GT4 and GT1 patients with CKD stages 4‐5. SVR12 rates were high regardless of patient characteristics.This article is protected by copyright. All rights reserved.

Source: Liver International - December 30, 2017 Category: Gastroenterology Authors: Faisal M. Sanai, Abdullah S. Alghamdi, Ahmad A Afghani, Khalid Alswat, Adnan AlZanbagi, Mosfer N Alghamdi, Abdallah AlMousa, Mohammed Aseeri, Abdullah M Assiri, Mohamed A. Babatin Tags: Original Article Source Type: research